Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Pharma
Argenx preps next potential Vyvgart nod after ph. 3 win
With its latest trial readout for under-the-skin efgartigimod, argenx is adding another feather to the FcRn blocker’s cap.
Fraiser Kansteiner
Aug 17, 2026 10:52am
Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie
Jul 30, 2026 2:15pm
Sanofi survey reveals diabetes misconceptions and screening gaps
Jul 20, 2026 2:14pm
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
Kyverna taps CCO as CAR-T autoimmune first comes into view
May 5, 2026 9:18am
AZ's Ultomiris hits goal in ph. 3 IgAN trial
Apr 21, 2026 10:35am
